In a patent litigation among medical device manufacturers, CRA was asked to assess damages suffered by plaintiff for alleged infringement of patents on bone compression plates. CRA examined lost profit and reasonable royalty damages, finding that a royalty would have been capped at the cost of implementing a viable non-infringing alternative. CRA provided an expert report and deposition testimony.
Patent damages jury verdicts aren't always end of the story
It has been over three years since Intel Corporation was ordered by a federal jury to pay VLSI Technology LLC over $2 billion in damages. During that time, the...